Powered by
Global Ophthalmology Drugs Market Briefing 2017-2020 - Research and Markets

The "Ophthalmology Drugs Market Global Briefing 2017" report has been added to Research and Markets' offering.

The global ophthalmology drugs market is expected to reach around $33 billion in 2020.

The ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azop

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox